A phase II study of olaparib in recurrent IDH mutated high grade gliomas

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2018
This article has no abstract
Epistemonikos ID: b1c525b8df26ca859c7d4fc9b29f955f65e09a11
First added on: Jan 23, 2025